Netcapital (NCPL) had the highest return between March 15, 2019 and March 25, 2019 by a US stock, returning 100%.
| ASSET | DATE | % RETURN |
|---|---|---|
Netcapital (NCPL) | 3/15/2019 - 3/25/2019 | 100% |
Biovie (BIVI) | 3/15/2019 - 3/25/2019 | 90.38% |
Daré Bioscience (DARE) | 3/15/2019 - 3/25/2019 | 85.56% |
Jaguar Animal Health (JAGX) | 3/15/2019 - 3/25/2019 | 74.19% |
Catalyst Pharmaceuticals (CPRX) | 3/15/2019 - 3/25/2019 | 74.09% |
Nutex Health (NUTX) | 3/15/2019 - 3/25/2019 | 57.89% |
TuHURA Biosciences (HURA) | 3/15/2019 - 3/25/2019 | 57.1% |
Tanzanian Royalty Exploration (TRX) | 3/15/2019 - 3/25/2019 | 54.98% |
Iterum Therapeutics (ITRM) | 3/15/2019 - 3/25/2019 | 54.34% |
Cyclerion Therapeutics (CYCN) | 3/15/2019 - 3/25/2019 | 52% |
Axsome Therapeutics (AXSM) | 3/15/2019 - 3/25/2019 | 50.05% |
Viracta Therapeutics (VIRX) | 3/15/2019 - 3/25/2019 | 47.12% |
Shineco (SISI) | 3/15/2019 - 3/25/2019 | 46.42% |
Star Equity (STRR) | 3/15/2019 - 3/25/2019 | 45.83% |
Performance Shipping (PSHG) | 3/15/2019 - 3/25/2019 | 44.83% |
Nevro (NVRO) | 3/15/2019 - 3/25/2019 | 44.77% |
American Rebel (AREB) | 3/15/2019 - 3/25/2019 | 41.54% |
Dianthus Therapeutics (DNTH) | 3/15/2019 - 3/25/2019 | 41.12% |
Skye Bioscience, Inc Common Stock (SKYE) | 3/15/2019 - 3/25/2019 | 40% |
Up Fintech (TIGR) | 3/15/2019 - 3/25/2019 | 39.33% |
Avita Medical (RCEL) | 3/15/2019 - 3/25/2019 | 39.21% |
Immunitybio (IBRX) | 3/15/2019 - 3/25/2019 | 38.02% |
Krystal Biotech (KRYS) | 3/15/2019 - 3/25/2019 | 37.59% |
DiaMedica Therapeutics (DMAC) | 3/15/2019 - 3/25/2019 | 37.1% |
Ainos (AIMD) | 3/15/2019 - 3/25/2019 | 36.36% |
